Skip to main content
Account

Peer review reports

From: Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study

Original Submission
9 Apr 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 May 2024 Reviewed Reviewer Report
13 May 2024 Reviewed Reviewer Report
25 May 2024 Reviewed Reviewer Report - Daishi Hirano
27 May 2024 Reviewed Reviewer Report
13 Jun 2024 Author responded Author comments - Gurdeep Singh Dhooria
Resubmission - Version 3
13 Jun 2024 Submitted Manuscript version 3
30 Jun 2024 Reviewed Reviewer Report - Daishi Hirano
1 Aug 2024 Author responded Author comments - Gurdeep Singh Dhooria
Resubmission - Version 4
1 Aug 2024 Submitted Manuscript version 4
7 Aug 2024 Author responded Author comments - Gurdeep Singh Dhooria
Resubmission - Version 5
7 Aug 2024 Submitted Manuscript version 5
14 Aug 2024 Author responded Author comments - Gurdeep Singh Dhooria
Resubmission - Version 6
14 Aug 2024 Submitted Manuscript version 6
20 Aug 2024 Author responded Author comments - Gurdeep Singh Dhooria
Resubmission - Version 7
20 Aug 2024 Submitted Manuscript version 7
Publishing
30 Aug 2024 Editorially accepted
9 Sep 2024 Article published 10.1186/s12882-024-03739-z

Learn about peer review

Back to article page

Navigation